Seminars in Radiation Oncology
Volume 20, Issue 3 , Pages 192-200 , July 2010

Current Status of Postoperative Radiation for Non–Small-Cell Lung Cancer

  • Mert Saynak, MD

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • Department of Radiation Oncology, Trakya University Hospital, Edirne, Turkey
    • ,
  • Daniel S. Higginson, MD

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • David E. Morris, MD

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • ,
  • Lawrence B. Marks, MD

      Affiliations

    • Department of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC
    • Corresponding Author InformationAddress reprint requests to Lawrence B. Marks, MD, Department of Radiation Oncology, University of North Carolina, Campus Box 7512, 101 Manning Drive, Chapel Hill, NC 27514

References 

  1. Kelsey CR, Marks LB, Hollis D, et al. Local recurrence after surgery for early stage lung cancer: An 11-year experience with 975 patients. Cancer. 2000;115:5218–5227
  2. Saynak M, Veeramachaneni NK, Hubbs JL, et al: Local failure after Complete resection of “Early-Stage” non-small cell lung cancer: The potential role of post-operative radiation therapy. Poster presentation at the 51st Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), November 1-5, 2009, Chicago, IL
  3. The Lung Cancer Study Group. Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. N Engl J Med. 1986;315:1377–1381
  4. Stephens RJ, Girling DJ, Bleehen NM, et al. The role of post-operative radiotherapy in non-small-cell lung cancer: A multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 disease (Medical Research Council Lung Cancer Working party). Br J Cancer. 1996;74:632–639
  5. Mayer R, Smolle-Juettner FM, Szolar D, et al. Postoperative radiotherapy in radically resected non-small cell lung cancer. Chest. 1997;112:954–959
  6. Van Houtte P, Rocmans P, Smets P, et al. Postoperative radiation therapy in lung caner: A controlled trial after resection of curative design. Int J Radiat Oncol Biol Phys. 1980;6:983–986
  7. PORT Meta-analysis Trialists Group. Postoperative radiotherapy in non-small-cell lung cancer: Systematic review and meta-analysis of individual patient data from nine randomised controlled trials. Lancet. 1998;352:257–263
  8. Wang M, Gu XZ, Yin WB, et al. Randomised clinical trial of postoperative irradiation after surgery for non-small cell lung carcinoma. Chin J Radiol Oncol. 1994;3:39–43
  9. Lafitte JJ, Ribet ME, Prevost BM, et al. Postresection irradiation for T2N0M0 non-small cell carcinoma: A prospective, randomized study. Ann Thorac Surg. 1996;62:830–834
  10. Dautzenberg B, Arriagada R, Chammard AB, et al. A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma; Groupe d: Etude et de Traitement des cancers Bronchiques. Cancer. 1999;86:265–273
  11. Debevec M, Bitenc M, Vidmar S, et al. Postoperative radiotherapy for radically resected N2 non-small-cell lung cancer (NSCLC): Randomised clinical study 1988-92. Lung Cancer. 1996;14:99–107
  12. Trodella L, Granone P, Valente S, et al. Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: Definitive results of a phase III randomized trial. Radiother Oncol. 2002;62:11–19
  13. Miles EF, Kelsey CR, Kirkpatrick JP, et al. Estimating the magnitude and field-size dependence of radiotherapy-induced mortality and tumor control after postoperative radiotherapy for non-small-cell lung cancer: Calculations from clinical trials. Int J Radiat Oncol Biol Phys. 2007;68:1047–1052
  14. Lally BE, Zelterman D, Colasanto JM, et al. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. J Clin Oncol. 2006;24:2998–3006
  15. Matsuguma H, Nakahara R, Ishikawa Y, et al. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: Focusing on an effect of the number of mediastinal lymph node stations involved. Interact Cardiovasc Thorac Surg. 2008;7:573–577
  16. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med. 2004;350:351–360
  17. Douillard JY, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (adjuvant Navelbine International Trialist Association [Anita]): A randomised controlled trial. Lancet Oncol. 2006;7:719–727
  18. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med. 2005;352:2589–2597
  19. Dautzenberg B, Chastang C, Arriagada R, et al. GETCB (Groupe d'Etude et de Traitement des Cancers Bronchiques) Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma (A randomized trial of 267 patients). Cancer. 1995;76:779–786
  20. Keller SM, Adak S, Wagner H, et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer (Eastern Cooperative Oncology Group). N Engl J Med. 2000;343:1217–1222
  21. Bradley JD, Paulus R, Graham MV, et al. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: Promising long-term results of the Radiation Therapy Oncology Group—RTOG 9705. J Clin Oncol. 2005;23:3480–3487
  22. Feigenberg SJ, Hanlon AL, Langer C, et al. A phase II study of concurrent carboplatin and paclitaxel and thoracic radiotherapy for completely resected stage II and IIIA non-small cell lung cancer. J Thorac Oncol. 2007;2:287–292
  23. Douillard JY, Rosell R, De Lena M, et al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: The adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Int J Radiat Oncol Biol Phys. 2008;72:695–701
  24. Perry MC, Kohman LJ, Bonner JA, et al. A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer (Cancer and Leukemia Group B). Clin Lung Cancer. 2007;8:268–272
  25. Wind J, Smit EJ, Senan S, et al. Residual disease at the bronchial stump after curative resection for lung cancer. Eur J Cardiothorac Surg. 2007;32:29–34
  26. Kaiser LR, Fleshner P, Keller S, et al. Significance of extramucosal residual tumor at the bronchial resection margin. Ann Thorac Surg. 1989;47:265–269
  27. Law MR, Henk JM, Lennox SC, et al. Value of radiotherapy for tumour on the bronchial stump after resection for bronchial carcinoma. Thorax. 1982;37:496–499
  28. Gebitekin C, Gupta NK, Satur CM, et al. Fate of patients with residual tumour at the bronchial resection margin. Eur J Cardio Thorac Surg. 1994;8:339–342
  29. Kelsey CR, Clough RW, Marks LB. Local recurrence following initial resection of NSCLC: Salvage is possible with radiation therapy. Cancer J. 2006;12:283–288
  30. Kelsey CR, Light KL, Marks LB. Patterns of failure after resection of non-small-cell lung cancer: Implications for postoperative radiation therapy volumes. Int J Radiat Oncol Biol Phys. 2006;65:1097–1105
  31. Kocak Z, Yu X, Zhou SM, et al. The impact of pre-radiotherapy surgery on radiation-induced lung injury. Clin Oncol R Coll Radiol. 2005;17:210–216
  32. Miles EF, Larrier NA, Kelsey CR, et al. Intensity-modulated radiotherapy for resected mesothelioma: The Duke Experience. Int J Radiat Oncol Biol Phys. 2008;71:1143–1150
  33. Yorke ED, Jackson A, Rosenzweig KE, et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:672–682
  34. Hernando ML, Marks LB, Bentel GC, et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys. 2001;51:650–659
  35. Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): Predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys. 2006;65:1075–1086
  36. Wang S, Liao Z, Wei X, et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys. 2006;66:1399–1407
  37. Seppenwoolde Y, De Jaeger K, Boersma LJ, et al. Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;60:748–758
  38. Hope AJ, Lindsay PE, El Naqa I, et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys. 2006;65:112–124
  39. Martel MK, ten Haken RK, Hazuka MB, et al. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys. 1994;28:575–581
  40. Oetzel D, Schraube P, Hensley F, et al. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 1995;33:455–460
  41. Rancati T, Ceresoli GL, Gagliardi G, et al. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol. 2003;67:275–283
  42. Kim TH, Cho KH, Pyo HR, et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology. 2005;235:208–215
  43. Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose volume effects in the lung. Int J Radiat Oncol Biol Phys. 2010;76(suppl 3):S70–S76
  44. Feng QF, Wang M, Wang LJ, et al. A study of postoperative radiotherapy in patients with non-small-cell lung cancer: A randomized trial. Int J Radiat Oncol Biol Phys. 2000;47:925–929
  45. Muller G, Kiricuta IC, Stiess J, et al. [Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma]. Strahlenther Onkol. 1994;170:400–407
  46. Monson JM, Stark P, Reilly JJ, et al. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer. 1998;82:842–850
  47. Pickel H, Lahousen M, Petru E, et al. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol. 1999;72:215–219
  48. Sorbe B, Ovarian S-N Cancer Study Group. Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: A randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer. 2003;13:278–286
  49. Umsawasdi T, Valdivieso M, Chen TT, et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol. 1984;2:253–259
  50. Stuschke M, Eberhardt W, Pottgen C, et al. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigations of late neuropsychologic effects. J Clin Oncol. 1999;17:2700–2709
  51. Pottgen C, Eberhardt W, Grannass A, et al. Prophylactic cranial irradiation in operable stage IIIA nonsmall-cell lung cancer treated with neoadjuvant chemoradiotherapy: Results from a German multicenter randomized trial. J Clin Oncol. 2007;25:4987–4992
  52. Quaranta BP, Light KL, Das S, et al. Utility of non-axial beams for treatment of lower lobe lung cancers. Int J Radiat Oncol Biol Phys. 2002;54:337-337

 Mert Saynak was funded by grants from the Turkish Association of Radiation Oncology.

PII: S1053-4296(10)00016-0

doi: 10.1016/j.semradonc.2010.01.008

Seminars in Radiation Oncology
Volume 20, Issue 3 , Pages 192-200 , July 2010

Article Tools

* Image Usage & Resolution